| Search for content and authors |
|
|
| |
 |
dr Marcin Cybulski
|
| e-mail: | ***@ifarm.eu |
| phone: | |
| fax: | |
| web: | |
| interest(s): | |
|
Affiliation: |
Instytut Farmaceutyczny |
Participant: |
| began: | 2008-05-25 |
| ended: | 2008-05-29 |
| Presented: | |
|
|
|
Participant: |
| began: | 2010-05-09 |
| ended: | 2010-05-13 |
| Presented: | |
|
|
|
Participant: |
|
Participant: |
|
Publications: |
- Determination of organic volatile impurities in Nepafenac by GC method
- Determination of reaction progress in synthesis of EE-3 by NMR technique
- Efficient preparation of a key intermediate in the exemestane synthesis
- Evaluation of potential genotoxic impurities in prasugrel intermediate by HPLC chromatography
- Exploration of sugar-based inhibitors of glycolysis to target brain tumors
- HPLC as a method for analytical control of synthesis and determination of tolterodine (TD-S)
- Searching for lead molecules as potential new CNS agents in the serotonin 5-HT6 screening assay
- Simultaneous CE determination of counterion and possible impurity from synthetic route in pharmaceutical substance prasugrel hydrochloride.
- The evaluation of tolterodine tartrate synthesis based on patent EP 0 325 574 B1.
|
